Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-13

Clinical Trial Update: Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of a dietary supplement containing L-Arabinose and a trivalent chromium source on blood glucose and insulin in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arabinose and Trivalent Patented Food-source of Chromium dietary supplement

Snippet

Sponsor: Integrative Health Technologies, Inc. | Conditions: Pre-diabetes | NA | Status: COMPLETED